TORONTO – September 11, 2018 (Investorideas.com Newswire) Revive Therapeutics Ltd. (TSX VENTURE: RVV) (OTCQB: RVVTF) (FSE: 31R) (“Revive” or the “Company”), a specialty cannabis company focused on the research, development and commercialization of novel cannabinoid-based products, today announced the introduction of RELICANN™, the Company’s hemp-based and medical cannabis brand designed for the health and wellness and medical cannabis consumer. The Company’s first product under the RELICANN™ brand is RELICANN™ hemp-based Cannabidiol (“CBD”) gum, which will be available in Canada in the fourth-quarter of 2018.
“We are excited to introduce the RELICANN™ brand, which focuses on the health and wellness and medical cannabis market targeting those who seek novel dosage forms of hemp-based and cannabis solutions over conventional ones,” said Fabio Chianelli, President of Revive. “RELICANN™ hemp-based CBD gum will be our first of several unique dosage forms of hemp-based and cannabis products to be launched in Canada, including
... read more at: https://www.investorideas.com/news/2018/cannabis/09114TSXVRVV.asp